Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Aspirin 325 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and meprobamate 200 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and methocarbamol 400 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and pravastatin 80 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and pravastatin 40 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and pravastatin 20 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and codeine 30 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and codeine 60 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Product containing precisely isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Paracetamol 325 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Paracetamol 325 mg oral capsule |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
4 |
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
3 |
Quinine sulfate 325 mg oral capsule |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
3 |
Aspirin 325 mg and carisoprodol 200 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and methocarbamol 400 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 5 mg and paracetamol 325 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
3 |
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely paracetamol 325 milligram and tramadol 37.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Butalbital 50 mg and paracetamol 325 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and pravastatin 80 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and pravastatin 40 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and pravastatin 20 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and codeine 30 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and codeine 60 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Product containing precisely dextropropoxyphene napsylate 100 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Product containing precisely butalbital 50 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Product containing precisely paracetamol 325 milligram and tramadol 37.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Hydrocodone bitartrate 2.5 mg and paracetamol 325 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Product containing precisely oxycodone hydrochloride 5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 10 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Butalbital 50 mg and paracetamol 325 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 2.5 mg and paracetamol 325 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Hydrocodone bitartrate 5 mg and paracetamol 325 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Oxycodone hydrochloride 7.5 mg and paracetamol 325 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
2 |
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
3 |
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Chloral hydrate 325 mg rectal suppository |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely dextropropoxyphene hydrochloride 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely sodium salicylate 325 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely aspirin 325 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
3 |
Paracetamol 325 mg rectal suppository |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |
Product containing precisely ferrous sulfate 325 milligram/1 each prolonged-release oral tablet (clinical drug) |
Has presentation strength numerator value |
False |
325 |
Inferred relationship |
Some |
1 |